Contact Us

Novo Nordisk pulls Wegovy from Hims/Hers

Hims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make its weight loss drug Wegovy available on the telehealth company’s platform.

Novo Nordisk cited concerns about Hims & Hers selling and promoting knock-off compounded GLP-1 drugs, which are more affordable versions of the popular weight loss medications.

Direct access to Wegovy will no longer be available to Hims & Hers Health via the company’s online pharmacy, NovoCare Pharmacy, the company said in a press release.

Click here for more info

Advasur

The DSCSA 360™Program provides you with all the tools to comply with the DSCSA Requirements by combining the ADVASUR 360™ from ADVASUR and DRUGSUPPLYTrack from PRS. The program includes all of the below features and tools to ensure 360 degrees of DSCSA (Drug Supply Chain Security Act) Compliance:

  1. Easy to follow Compliance Guide to walk you through the implementation process
  2. Required Policies and Procedures/SOPs
  3. Required forms
  4. Support from Compliance experts to help you at every step of the process
  5. Works, on your behalf, with your authorized trading partners to begin collecting your electronic transaction data automatically
  6. Provides all of the electronic transaction data from all your authorized trading partners on one easy-to-use website
  7. Provides alerts to you when there is suspect data in your transaction information
  8. Provides alerts to you when recall information matches products you have received
  9. Provides alerts to you when your authorized trading partner licenses and credentials are expiring
  10. DSCSA Audit assistance is available at no cost
  11. Provides Employee Training on the Software and SOPs

Training and education on identifying suspect products

  • Joshua Potter
  • 1-800-338-3688 Ext 204
  • josh@prsrx.com
  • www.prsrx.com/dscsa360/
  • Mention you are a Keystone Member
Click Here to Get Started